MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)

    JP. Azulay, D. Grabli, S. Benard, N. Kabore, MS. Behier (Marseille, France)

    Objective: To quantify the number of French aPD patients initiating continuous delivery of LCIG from 2013 to 2017 and to describe their demographic, clinical and…
  • MDS Virtual Congress 2021

    Is past use of statins associated with lower incidence of Parkinson’s disease?

    TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…
  • MDS Virtual Congress 2021

    Virtual Rehabilitation for Functional Movement Disorder

    H. Bhatt, L. Macgillivray, K. Marcelle, S. Lidstone (Toronto, Canada)

    Objective: We describe initial experiences using virtual rehabilitation in a specialized outpatient functional movement disorder (FMD) clinic. Background: Specialized rehabilitation programs have been shown to…
  • MDS Virtual Congress 2021

    HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family

    A. Orlacchio, M. Stasi, A. Stigliano, A. Meyyazhagan, T. Kawarai (Rome, Italy)

    Objective: To carry out a clinical and genetic study of a large Indian family emigrated in Italy with autosomal dominant hereditary spastic paraplegia (ADHSP). Background:…
  • MDS Virtual Congress 2021

    Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease

    J. Gamez, M. Calopa, E. Muñoz, A. Ferré, O. Huertas, K. Mcallister, N. Reig, C. Scart-Grès, R. Insa, J. Kulisevsky (Barcelona, Spain)

    Objective: Proof-of-concept phase IIa study assessing bevantolol (SOM3355) efficacy and safety in reducing chorea in Huntington’s disease (HD). Background: Bevantolol hydrochloride, a β1‐adrenoceptor antagonist used…
  • MDS Virtual Congress 2021

    The Huntington’s Disease Structured Interview of Function (HD-SIF): A remotely administered caregiver interview for later stage HD

    M. Roche, R. Fuller, L. Cherneski, O. Handley, S. Capodarca, E. Neacy, S. Frank, G. Stebbins, S. Sathe, C. Sampaio (Princeton, USA)

    Objective: To create structured interviews for the UHDRS ’99 functional scales that can be remotely administered to caregivers of Huntington’s disease gene expansion carriers (HDGECs)…
  • MDS Virtual Congress 2021

    Spinal myoclonus in secondary progressive multiple sclerosis

    N. Raisa, B. Munir, S. Rianawati (Malang, Indonesia)

    Objective: We report a rare case of secondary progressive multiple sclerosis with one of the manifestation was spinal myoclonus. Background: Myoclonus is a sudden and…
  • MDS Virtual Congress 2021

    The effects of acute administration of VMAT2 inhibitors on extracellular levels of dopamine, norepinephrine, 5-HT and histamine in the striatum and medial prefrontal cortex

    E. Adler, L. Magid, O. Even-Chen, S. Schmidt, I. Cope, J. Alexander, J. Kehr, A. Orbach (Netanya, Israel)

    Objective: To evaluate the effects of reversible VMAT2 inhibitors (deutetrabenazine, tetrabenazine and valbenazine) on extracellular levels of monoamines and their acidic metabolites in rat striatum…
  • MDS Virtual Congress 2021

    Closing the Loop on Essential Tremor Using Thalamic and Cortical Control Signals

    B. Parks, A. Gunduz, K. Foote (Gainesvile, USA)

    Objective: In this study, we show feasibility of a novel embedded closed-loop DBS (CL-DBS) that uses local field potential (LFP) oscillations of the alpha/beta band…
  • MDS Virtual Congress 2021

    Evaluation of Care delivery model for integrated care and self-management for people with Parkinson’s disease with Deep Brain Stimulation

    D. Dash, D. Cote, J. Conway, A. Basndwah, D. Grimes, T. Mestre (Ottawa, Canada)

    Objective: To evaluate the implementation and impact potential of a pragmatic network for PD care, the Integrated Parkinson Care Network (IPCN) for patients with chronic…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley